Results 131 to 140 of about 120,253,457 (190)

Three decades of experience with therapeutic apheresis at a tertiary academic center: review of indications, clinical practice, special age groups and complications. [PDF]

BMC Nephrol
Jerman A, Andonova M, Čede AŽ, Fornazarič D, Gubenšek J, Pernat AM, Medved B, Ponikvar R, Romozi K, Trampuž BV, Zrimšek M, Peršič V.   +11 more
europepmc   +1 more source

Intermittent immunoadsorption in critically ill patients with neuroimmunological disorders: a retrospective study. [PDF]

Front Neurol
Wu Q, Zhu L, Dai S, Xu J, Ge D.
europepmc   +1 more source

The Comprehensive Live Cell-Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD. [PDF]

Ann Clin Transl Neurol
Xu X, Ding J, Du Y, Luo G, Li J, Liu R, Xu X, Li X, Li M, Jiang W, Yang C.   +10 more
europepmc   +1 more source

Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration. [PDF]

J Transl Autoimmun
Rafiq M, Varenne F, Pariente J, Ory-Magne F, Wolfrum M, Gérard F, Virchien L, Pinto AL, Joubert B, Fortenfant F, Biotti D, Bost C.   +11 more
europepmc   +1 more source

Triple islet autoantibody-positive type 1 diabetes in Japanese stiff-person syndrome despite a protective HLA haplotype. [PDF]

JCEM Case Rep
Suenaga M, Ogiso K, Takeuchi N, Akahoshi H, Nishio Y, Morino K.   +5 more
europepmc   +1 more source

Daratumumab combined with anti-CD20 therapy in pediatric and adult refractory idiopathic nephrotic syndrome: single-center experience. [PDF]

Front Immunol
Naciri Bennani H, Sandaye T, Charroyer Q, Etangsale A, Vacher Coponat H, Julien M, Mear V, Dunand O, Di Ascia L.   +8 more
europepmc   +1 more source

Preliminary observations on the efficacy of efgartigimod in anti-LGI1-associated autoimmune encephalitis. [PDF]

Ther Adv Neurol Disord
Zuo JW, Dai YY, Liu WJ, Zhang JY, Shao XQ, Wang Q, Lv RJ.   +6 more
europepmc   +1 more source

Distinct anti-MDA5 antibody trajectories associated with long-term outcomes in 6-month survivors of anti-MDA5 dermatomyositis with interstitial lung disease. [PDF]

Respir Res
Chen Z, Wang H, Wu W, Fu Y, Xu W, Zhang D, Wang K, Wang X, Lu L, Ye S.   +9 more
europepmc   +1 more source

Bridging metabolism and immuno-inflammation: a novel framework to characterize dilated cardiomyopathy subtype. [PDF]

J Transl Med
Yu C, Liu C, Liu B, Feng J, Deng Y, Yuan J.   +5 more
europepmc   +1 more source

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood Purif
Gallegos FR, Vala K, Hu J, Sethi SK, Spyres D, Safadi R, Tanna S, Kapadia S, Duzova A, Antwi SK, Raina R.   +10 more
europepmc   +1 more source